Hydrochloric Acid

Hydrochloric Acid

SCHEMBL315435

CCCCCCCCCCCCCCCC[N+](CC)(C(C)O)C(C)O.[Cl-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.44
SLC22A1 O15245 1/20 0.44
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HSP90AA1 P07900 1/20 0.41
RAD52 P43351 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2772679 0.91 DNM1 (0.48) DNM1SLC22A1HTTALDH1A1TP53
Hydrochloric Acid SCHEMBL4603559 0.91 DNM1 (0.48) DNM1SLC22A1HTTALDH1A1TP53
Hydrochloric Acid SCHEMBL2764924 0.89 DNM1 (0.43) DNM1SLC22A1HTTKMT2AALDH1A1
Water SCHEMBL17222518 0.86 SLC22A1 (0.48) DNM1SLC22A1HTTALDH1A1TP53
Bromide SCHEMBL557385 0.86 ALDH1A1 (0.52) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL8500446 0.81 SLC22A1 (0.41) DNM1SLC22A1TSHRHSD17B10RAD52
SCHEMBL302025 0.79 DNM1 (0.50) DNM1SLC22A1HTTKMT2AALDH1A1
SCHEMBL17222516 0.79 SLC22A1 (0.41) DNM1SLC22A1HTTALDH1A1TP53
SCHEMBL15216634 0.79 SLC22A1 (0.41) DNM1SLC22A1HTTALDH1A1TP53
SCHEMBL8500577 0.79 SLC22A1 (0.43) DNM1SLC22A1ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001051767-A2 ADDITION OF SOLIDS TO GENERATE VISCOSITY DOWNHOLE SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2001-07-19 WO claimed
US-20260042956-A1 METHOD FOR SINGLE-STAGE TREATMENT OF SILICEOUS SUBTERRANEAN FORMATIONS SCHLUMBERGER TECHNOLOGY CORPORATION 2026-02-12 US disclosed
WO-2024026137-A1 METHOD FOR SINGLE-STAGE TREATMENT OF SILICEOUS SUBTERRANEAN FORMATIONS SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2024-02-01 WO disclosed
US-10190032-B2 Viscoelastic surfactants in mixed brines M-I L.L.C. (US) 2019-01-29 US disclosed
US-20180105733-A1 EARLY VISCOSITY ENHANCEMENT OF GELLED OIL SCHLUMBERGER TECHNOLOGY CORPORATION 2018-04-19 US disclosed
WO-2016187364-A1 METHODS USING VISCOELASTIC SURFACTANT BASED ABRASIVE FLUIDS FOR PERFORATION AND CLEANOUT SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2016-11-24 WO disclosed
US-20160341017-A1 Methods Using Viscoelastic Surfactant Based Abrasive Fluids for Perforation and Cleanout SCHLUMBERGER TECHNOLOGY CORPORATION 2016-11-24 US disclosed
US-20160108303-A1 VISCOELASTIC SURFACTANTS IN MIXED BRINES M-I L.L.C. (US) 2016-04-21 US disclosed
US-20160009977-A1 DELAYED ENHANCEMENT OR BREAKING OF VISCOSITY FOR VISCOELASTIC SURFACTANT CONTAINING WELLBORE FLUIDS M-I L.L.C. 2016-01-14 US disclosed
US-9121674-B2 Armor MILMARK TECHNOLOGIES, INC. (US) 2015-09-01 US disclosed
US-6306800-B1 USING AMINE OR SALT, WATER SOLUBLE SALT AND ORGANIC STABILIZER SCHLUMBERGER TECHNOLOGY CORPORATION 2001-10-23 US disclosed
WO-2001051767-A2 ADDITION OF SOLIDS TO GENERATE VISCOSITY DOWNHOLE SCHLUMBERGER TECHNOLOGY CORPORATION (US) 2001-07-19 WO disclosed
US-5979557-A Methods for limiting the inflow of formation water and for stimulating subterranean formations SCHLUMBERGER TECHNOLOGY CORPORATION (US) 1999-11-09 US disclosed
US-5964295-A FOR REDUCING FLUID LOSS DURING FRACTURING OF A FORMATION SCHLUMBERGER TECHNOLOGY CORPORATION, DOWELL DIVISION (US) 1999-10-12 US disclosed
EP-0835983-A2 Methods of fracturing subterranean formations SOFITECH N.V. (BE) 1998-04-15 EP disclosed
US-5551516-A VISCOELASTIC SURFACTANT BASED AQUEOUS FLUID SYSTEMS USING A QUATERNARY AMMONIUM HALIDE THICKENER DOWELL, A DIVISION OF SCHLUMBERGER TECHNOLOGY CORPORATION 1996-09-03 US disclosed
US-4725372-A WATER SOLUBLE ELECTROLYTE AND QUATERNARY AMMONIUM SALT THE DOW CHEMICAL COMPANY (US) 1988-02-16 US disclosed
EP-0142028-B1 REVERSIBLE PHASE CHANGE COMPOSITION FOR STORING THERMAL ENERGY THE DOW CHEMICAL COMPANY (US) 1987-08-05 EP disclosed
US-4585572-A CATIONIC SURFACTANT THICKENER THE DOW CHEMICAL COMPANY (US) 1986-04-29 US disclosed
EP-0142028-A1 Reversible phase change composition for storing thermal energy THE DOW CHEMICAL COMPANY (US) 1985-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042956-A1 METHOD FOR SINGLE-STAGE TREATMENT OF SILICEOUS SUBTERRANEAN FORMATIONS YAP1, S100A10, FOXM1 DNM1 925/4885SLC22A1 1050/4885HTT 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.